Table 1.

Baseline Characteristics in the Overall Population and Subgroups of Those Who Take and Do Not Take Calcium Supplementation *

VariableOverall(n = 257)No Supplement(n = 232)Supplement(n = 25)P
Age (yr)67.8 ± 5.267.7 ± 5.168.5 ± 5.9.45
Male Gender (n [%])113 (44)113 (49)0 (0)<.001
Body Mass Index (kg/m2)28.6 ± 5.128.8 ± 5.127.2 ± 4.7.13
Age <70 years (n [%])168 (65)154 (66)14 (56).3
Smoking (pack/yr)13.7 ± 21.814.5 ± 22.36.5 ± 14.1.08
History of HTN (n [%])140 (54)128 (55)12 (48).49
Treated DM (n [%])25 (10)24 (10)1 (4).31
Tchol (mg/dL)209.6 ± 34.6207.9 ± 34.7225 ± 30.1.018
LDL (mg/dL)121.9 ± 29.0121.3 ± 29.2127.8 ± 27.3.28
HDL (mg/dL)52.6 ± 15.751.8 ± 15.760.1 ± 13.3.012
TG (mg/dL)176.9 ± 81.4175.9 ± 82.2185.8 ± 74.6.57
CAC score (base)317.5 ± 645.4346.3 ± 672.650.4 ± 79.3.029
AVC score (base)54.5 ± 174.457.7 ± 181.625.4 ± 77.9.38
Serum calcium9.5 ± 0.39.5 ± 0.39.4 ± 0.3.88
GFR (MDRD)67.9 ± 14.767.7 ± 15.069.3 ± 12.7.62
  • * Data source: the Epidemiology of Coronary Artery Calcification (ECAC) study.12

  • HTN, hypertension; DM, diabetes mellitus; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; CAC, coronary artery calcification; AVC, aortic valve calcification; GFR, glomerular filtration rate; MDRD, Modification of Diet in Renal Disease equation.